We are in the middle of huge crisis and uncertainty. The Covid-19 crisis is taking a toll on Indian Pharma Leaders. Many leaders are not sure – what is of critical importance at this time? What are they are supposed to do and how they are supposed to do it?…
Healthcare systems around the world differ – public, private or a mix of both public and private (like in India). With all the variance in healthcare delivery models, the risks to healthcare professionals remain universal: needle injuries to litigations to episodes of threats/ violence
To me, patient centricity is as fascinating a concept as it is contradictory. It is fascinating because it puts power into the hands of the patient. And it is contradictory because pharma does not like giving away power over its messages or processes. Pharma has traditionally never enjoyed interaction and has depended on ‘pushing’ messages across rather than having ‘conversations’. It probably also explains why we make do with medical reps who are not the sharpest knives in the drawer and scarcely invest in sharpening them.
The COVID crisis has impacted IPM negatively – the growth seen in July 2020 was a mere 0.2%. This is down to -2.2% de-growth in August 2020 and shows a single digit growth of 4.1% on a MAT basis. #Cardiac has stabilized but with lower growth of 11.5% in August 2020…
The new sparkling DIME (Digi MarketEr) are the ones who embrace digital transformation with open arms and voraciously feed on data analytics to satisfy their performance outcomes with an informed business decision. The benefit of being DIME is that it propels data management out of the hands of individual stakeholders, and puts data sets with insights on to center glass table (Transparent workplace) for informed decision making.
“If we look at major trends, people are living longer, on average, so there’s a rise in chronic diseases associated with aging. Meanwhile, healthcare workers are in short supply, and physicians and nurses do not have enough time for patients. Yet everyone has powerful computers in their pockets that give them access to technology, education, and information. Put all that together, and it’s the perfect moment for digital solutions to come to the market, change behavior, and enhance health outcomes at scale”
– Bozidar Jovicevic, Global head of Digital Therapeutics, Sanofi
Yesterday I received a WhatsApp from a famous shoe company. A catalogue. The local store manager shared that with me and followed it up with a phone call to enquire if I have any footwear needs and assured that they will provide an immediate resolution. Although I appreciate the intent,…
It is well accepted that pharma field force access to doctors has been decreasing over the years. However, face to face interactions are preferred whenever the doctors think that they add value. The question then becomes one of how to define value. While different doctors will value different things, this…
The door to the magical realm is open! Are we awake? Traditional Pharma Business Model depended upon face to face visit of Medical Representatives to Health Care Practitioners (HCPs). Covid-19 pandemic makes it challenging to carry out the same. Therefore, like all other industries Pharma Marketers as well are in…
“Real digital transformation occurs when courageous leaders align goals in practice as well as theory, manage opportunity more than risk, and prioritise the future versus retrofit the present.” Indian Pharma companies are recognising that, due to COVID-19 and its impact on people and overall health systems, they are going to…